3 employees
ptTheragnostic focuses on the development of genomics-based personalized analysis for radiation sensitivity.
2014
$2.6M
from 1 investors over 1 rounds
PtTheragnostic raised $2.6M on June 1, 2015
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)